Kaye, P. M., Cruz, I., Picado, A., Van Bocxlaer, K., & Croft, S. L. (2020). Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs. Seminars in Immunopathology, 42(3), 247. https://doi.org/10.1007/s00281-020-00788-y
Chicago Style (17th ed.) CitationKaye, Paul M., Israel Cruz, Albert Picado, Katrien Van Bocxlaer, and Simon L. Croft. "Leishmaniasis Immunopathology—impact on Design and Use of Vaccines, Diagnostics and Drugs." Seminars in Immunopathology 42, no. 3 (2020): 247. https://doi.org/10.1007/s00281-020-00788-y.
MLA (9th ed.) CitationKaye, Paul M., et al. "Leishmaniasis Immunopathology—impact on Design and Use of Vaccines, Diagnostics and Drugs." Seminars in Immunopathology, vol. 42, no. 3, 2020, p. 247, https://doi.org/10.1007/s00281-020-00788-y.